Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Compass - Randomized Controlled Trial of 5-yearly Cervical Screening With Primary HPV Testing Versus Cervical Screening With 2.5-yearly Liquid Based Cytology Testing, in HPV-Unvaccinated and HPV-Vaccinated Women in Australia

NCT02328872 is registered in ClinicalTrials.gov with VCS Foundation as lead sponsor.

NCT NCT02328872
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02328872 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Compass - Randomized Controlled Trial of 5-yearly Cervical Screening With Primary HPV Testing Versus Cervical Screening With 2.5-yearly Liquid Based Cytology Testing, in HPV-Unvaccinated and HPV-Vaccinated Women in Australia
Lead sponsor
VCS Foundation
Phase
Not applicable
Overall status
Active, not recruiting
Start date
January 31, 2015
Completion date
March 31, 2037
Enrollment
76,181 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cancer of the cervix, cervical intraepithelial neoplasia